Sutro Biopharma (STRO)
(Delayed Data from NSDQ)
$0.81 USD
0.00 (0.58%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $0.81 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
STRO 0.81 0.00(0.58%)
Will STRO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for STRO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for STRO
Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last?
Exelixis (EXEL) Surges 7.4%: Is This an Indication of Further Gains?
STRO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Strength Seen in Nektar (NKTR): Can Its 12.1% Jump Turn into More Strength?
Strength Seen in CorMedix (CRMD): Can Its 21.7% Jump Turn into More Strength?
RGC Resources (RGCO) Surges 9.1%: Is This an Indication of Further Gains?
Other News for STRO
Sutro Biopharma (STRO) Partners with FDA to Advance ADC Development | STRO Stock News
Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards ...
Sutro Biopharma enters research collaboration with FDA for ADC standards
Sutro Biopharma Faces NASDAQ Non-Compliance Notice
Sutro, Sarepta, Incyte, Signet, Wix: Trending by Analysts